endeavorbiomedicines.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $163MM
Endeavor BioMedicines is a biotechnology company that is striving to discover new ways to treat patients who have life-threatening diseases. The company is working toward that goal by aiming to combat the drivers of fibrosis and oncology, which are both areas of medicine that have unmet needs. Endeavor BioMedicines was founded in 2018 by John Hood and Miguel de los Rios and is headquartered in San Diego, CA. In addition to looking for treatments that alleviate symptoms, Endeavor BioMedicines is seeking ways to reverse the effects of terminal illnesses.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Endeavor BioMedicines.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.